Every accelerated approval comes with a confirmatory-trial commitment. Under FDORA, FDA has expanded its authority over these trials — including requirements that may apply at approval and periodic progress reporting. Confirmatory-trial status matters to sponsors, investors, and competitors alike; this is public-record tracking, not regulatory or investment advice.
Live from FDA's public Project Confirm tables, refreshed daily by Eichor's always-on pipeline. The full watch tracks each drug in depth and alerts you the day a status moves. Early access is free — join the list:
"Past projected completion" reflects FDA's stated original projection — a projection, not a deadline or violation. Public data only; not investment advice.